1. Home
  2. |Insights
  3. |PODCAST: Announcing Crowell & Moring’s Regulatory Forecast 2019

PODCAST: Announcing Crowell & Moring’s Regulatory Forecast 2019

Client Alert | less than 1 min read | 02.28.19

On February 27, Crowell & Moring published its fifth annual Regulatory Forecast, exploring a diverse range of regulatory developments coming out of Washington and other leading regulatory centers of power.

The publication’s editors, Richard Lehfeldt and Dan Wolff, both partners in the firm’s Administrative Law and Regulatory Practice, sat down to discuss the forecast. In this 21 minute podcast, Richard and Dan discuss what you will find in our Regulatory Forecast 2019.

Click below to listen or access from the link:
SoundCloud

Insights

Client Alert | 7 min read | 06.26.26

Federal Roundup: Updates for PBMs and Medicare Advantage Organizations

In June 2026, federal regulators and lawmakers continued their efforts to improve drug affordability through targeted reforms. These recent developments will primarily impact pharmaceutical manufacturers, managed care organizations, and pharmacy benefit managers (PBM) serving Medicare Part D program members. PBMs, Medicare Advantage organizations, and Part D sponsors should monitor these changes in the interest of maintaining compliance and providing input on regulatory proposals that may influence their business operations or compensation structures in the future....